tiprankstipranks
DENTSPLY SIRONA (DE:DY2)
NASDAQ:DY2
Germany Market
DY2
DENTSPLY SIRONA
RESEARCH TOOLSreports

DENTSPLY SIRONA (DY2) Stock Forecast & Price Target

2 Followers
See the Price Targets and Ratings of:

DY2 Analyst Ratings

Hold
13Ratings
Hold
3 Buy
8 Hold
2 Sell
Based on 13 analysts giving stock ratings to
DENTSPLY
SIRONA
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

DY2 Stock 12 Month Forecast

Average Price Target

€12.14
▲(6.90% Upside)
Based on 13 Wall Street analysts offering 12 month price targets for DENTSPLY SIRONA in the last 3 months. The average price target is €12.14 with a high forecast of €14.92 and a low forecast of €7.90. The average price target represents a 6.90% change from the last price of €11.36.
{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"6":"€6","15":"€15","8.25":"€8.25","10.5":"€10.5","12.75":"€12.75"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":14.92395796,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">€14.92</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":12.144005006666664,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">€12.14</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":7.90091892,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">€7.90</span>\n  </div></div>","useHTML":true}}],"tickPositions":[6,8.25,10.5,12.75,15],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Oct<br/>2025","6":"Jan<br/>2026","9":"Apr<br/>2026","12":"Jul<br/>2026","25":"Jul<br/>2027"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,9.052,9.503689073846154,9.955378147692308,10.407067221538462,10.858756295384614,11.310445369230768,11.762134443076922,12.213823516923076,12.66551259076923,13.117201664615383,13.568890738461537,14.020579812307691,14.472268886153845,{"y":14.92395796,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,9.052,9.28984653897436,9.527693077948717,9.765539616923077,10.003386155897434,10.241232694871794,10.479079233846152,10.716925772820511,10.95477231179487,11.192618850769229,11.430465389743587,11.668311928717946,11.906158467692304,{"y":12.144005006666664,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,9.052,8.963455301538461,8.874910603076923,8.786365904615383,8.697821206153845,8.609276507692307,8.52073180923077,8.432187110769231,8.343642412307691,8.255097713846153,8.166553015384615,8.078008316923077,7.989463618461538,{"y":7.90091892,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":13.565,"date":1751328000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 5,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 21, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":11.911,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 5,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 23, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":11.702,"date":1756684800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 6,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 27, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":10.773,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 6,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 23, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":10.674,"date":1761955200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 5,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 19, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":9.436,"date":1764547200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 5,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 15, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":9.53,"date":1767225600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 16, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":10.245,"date":1769904000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 14, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":12.12,"date":1772323200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 5,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 14, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":9.998,"date":1775001600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Moderate Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 10, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 3</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":9.912,"date":1777593600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Moderate Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 7,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 9, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 4</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":8.778,"date":1780272000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Moderate Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 6,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 8, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 4</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":9.052,"date":1782864000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 6,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 10, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 3</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}
Highest Price Target€14.92Average Price Target€12.14Lowest Price Target€7.90
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Piper Sandler Analyst forecast on DE:DY2
Jason Bednar
Piper Sandler
Piper Sandler
€11.41→€12.29
Hold
8.19%
Upside
Reiterated
07/29/26
Piper Sandler Reaffirms Their Hold Rating on DENTSPLY SIRONA (XRAY)
Morgan Stanley Analyst forecast on DE:DY2
Erin Wright
Morgan Stanley
Morgan Stanley
―
Hold
―
Reiterated
07/24/26
Analysts Are Neutral on These Healthcare Stocks: DENTSPLY SIRONA (XRAY), Edwards Lifesciences (EW)
BMO Capital Analyst forecast on DE:DY2
Vik Chopra
BMO Capital
BMO Capital
€10.53
Hold
-7.27%
Downside
Initiated
07/09/26
Dentsply Sirona initiated with a Market Perform at BMO CapitalDentsply Sirona initiated with a Market Perform at BMO Capital
Leerink Partners Analyst forecast on DE:DY2
Michael Cherny
Leerink Partners
Leerink Partners
―
Hold
―
Reiterated
06/12/26
Analysts Conflicted on These Healthcare Names: United Therapeutics (NASDAQ: UTHR), DENTSPLY SIRONA (NASDAQ: XRAY) and Climb Bio (NASDAQ: CLYM)
Bank of America Securities Analyst forecast on DE:DY2
Allen Lutz
Bank of America Securities
Bank of America Securities
€14.92
Buy
31.37%
Upside
Reiterated
06/11/26
Wall Street Analysts Are Bullish on Top Healthcare Picks
Barclays Analyst forecast on DE:DY2
Glen Santangelo
Barclays
Barclays
€10.53→€7.9
Sell
-30.45%
Downside
Assigned
06/05/26
Dentsply Sirona price target lowered to $9 from $12 at BarclaysDentsply Sirona price target lowered to $9 from $12 at Barclays
UBS Analyst forecast on DE:DY2
Kevin Caliendo
UBS
UBS
€15.8→€14.92
Buy
31.37%
Upside
Reiterated
05/07/26
Dentsply Sirona price target lowered to $17 from $18 at UBSDentsply Sirona price target lowered to $17 from $18 at UBS
Stifel Nicolaus Analyst forecast on DE:DY2
Jonathan Block
Stifel Nicolaus
Stifel Nicolaus
€12.29
Hold
8.19%
Upside
Reiterated
05/06/26
Stifel Nicolaus Reaffirms Their Hold Rating on DENTSPLY SIRONA (XRAY)
Citi Analyst forecast on DE:DY2
Daniel Grosslight
Citi
Citi
€8.78→€9.22
Sell
-18.86%
Downside
Reiterated
05/06/26
DENTSPLY SIRONA (XRAY) Receives a Sell from Citi
Barrington Analyst forecast on DE:DY2
Michael Petusky
Barrington
Barrington
€14.92
Buy
31.37%
Upside
Reiterated
05/06/26
Analysts Offer Insights on Healthcare Companies: Xencor (NASDAQ: XNCR), DENTSPLY SIRONA (NASDAQ: XRAY) and Neurocrine (NASDAQ: NBIX)
Needham Analyst forecast on DE:DY2
David Saxon
Needham
Needham
―
Hold
―
Reiterated
05/06/26
Hold Rating Reaffirmed as FX-Driven Revenue Beat Offsets EPS Miss Amid Uneven ‘Return to Growth’ Path
Mizuho Securities Analyst forecast on DE:DY2
Steven Valiquette
Mizuho Securities
Mizuho Securities
€14.05→€12.29
Hold
8.19%
Upside
Reiterated
05/06/26
Dentsply Sirona price target lowered to $14 from $16 at MizuhoDentsply Sirona price target lowered to $14 from $16 at Mizuho
William Blair Analyst forecast on DE:DY2
Brandon Vazquez
William Blair
William Blair
―
Hold
―
Reiterated
05/06/26
Analysts Have Conflicting Sentiments on These Healthcare Companies: DENTSPLY SIRONA (NASDAQ: XRAY) and Jazz Pharmaceuticals (NASDAQ: JAZZ)
Evercore ISI Analyst forecast on DE:DY2
Elizabeth Anderson CFA
Evercore ISI
Evercore ISI
€13.17→€11.41
Hold
0.46%
Upside
Reiterated
04/08/26
Dentsply Sirona price target lowered to $13 from $15 at Evercore ISIDentsply Sirona price target lowered to $13 from $15 at Evercore ISI
Wells Fargo Analyst forecast on DE:DY2
Unknown Analyst
Wells Fargo
Not Ranked
Wells Fargo
€11.41
Hold
0.46%
Upside
Reiterated
02/27/26
Wells Fargo Keeps Their Hold Rating on DENTSPLY SIRONA (XRAY)
Analyst Type
Any
Any
Human Analysts
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Piper Sandler Analyst forecast on DE:DY2
Jason Bednar
Piper Sandler
Piper Sandler
€11.41→€12.29
Hold
8.19%
Upside
Reiterated
07/29/26
Piper Sandler Reaffirms Their Hold Rating on DENTSPLY SIRONA (XRAY)
Morgan Stanley Analyst forecast on DE:DY2
Erin Wright
Morgan Stanley
Morgan Stanley
―
Hold
―
Reiterated
07/24/26
Analysts Are Neutral on These Healthcare Stocks: DENTSPLY SIRONA (XRAY), Edwards Lifesciences (EW)
BMO Capital Analyst forecast on DE:DY2
Vik Chopra
BMO Capital
BMO Capital
€10.53
Hold
-7.27%
Downside
Initiated
07/09/26
Dentsply Sirona initiated with a Market Perform at BMO CapitalDentsply Sirona initiated with a Market Perform at BMO Capital
Leerink Partners Analyst forecast on DE:DY2
Michael Cherny
Leerink Partners
Leerink Partners
―
Hold
―
Reiterated
06/12/26
Analysts Conflicted on These Healthcare Names: United Therapeutics (NASDAQ: UTHR), DENTSPLY SIRONA (NASDAQ: XRAY) and Climb Bio (NASDAQ: CLYM)
Bank of America Securities Analyst forecast on DE:DY2
Allen Lutz
Bank of America Securities
Bank of America Securities
€14.92
Buy
31.37%
Upside
Reiterated
06/11/26
Wall Street Analysts Are Bullish on Top Healthcare Picks
Barclays Analyst forecast on DE:DY2
Glen Santangelo
Barclays
Barclays
€10.53→€7.9
Sell
-30.45%
Downside
Assigned
06/05/26
Dentsply Sirona price target lowered to $9 from $12 at BarclaysDentsply Sirona price target lowered to $9 from $12 at Barclays
UBS Analyst forecast on DE:DY2
Kevin Caliendo
UBS
UBS
€15.8→€14.92
Buy
31.37%
Upside
Reiterated
05/07/26
Dentsply Sirona price target lowered to $17 from $18 at UBSDentsply Sirona price target lowered to $17 from $18 at UBS
Stifel Nicolaus Analyst forecast on DE:DY2
Jonathan Block
Stifel Nicolaus
Stifel Nicolaus
€12.29
Hold
8.19%
Upside
Reiterated
05/06/26
Stifel Nicolaus Reaffirms Their Hold Rating on DENTSPLY SIRONA (XRAY)
Citi Analyst forecast on DE:DY2
Daniel Grosslight
Citi
Citi
€8.78→€9.22
Sell
-18.86%
Downside
Reiterated
05/06/26
DENTSPLY SIRONA (XRAY) Receives a Sell from Citi
Barrington Analyst forecast on DE:DY2
Michael Petusky
Barrington
Barrington
€14.92
Buy
31.37%
Upside
Reiterated
05/06/26
Analysts Offer Insights on Healthcare Companies: Xencor (NASDAQ: XNCR), DENTSPLY SIRONA (NASDAQ: XRAY) and Neurocrine (NASDAQ: NBIX)
Needham Analyst forecast on DE:DY2
David Saxon
Needham
Needham
―
Hold
―
Reiterated
05/06/26
Hold Rating Reaffirmed as FX-Driven Revenue Beat Offsets EPS Miss Amid Uneven ‘Return to Growth’ Path
Mizuho Securities Analyst forecast on DE:DY2
Steven Valiquette
Mizuho Securities
Mizuho Securities
€14.05→€12.29
Hold
8.19%
Upside
Reiterated
05/06/26
Dentsply Sirona price target lowered to $14 from $16 at MizuhoDentsply Sirona price target lowered to $14 from $16 at Mizuho
William Blair Analyst forecast on DE:DY2
Brandon Vazquez
William Blair
William Blair
―
Hold
―
Reiterated
05/06/26
Analysts Have Conflicting Sentiments on These Healthcare Companies: DENTSPLY SIRONA (NASDAQ: XRAY) and Jazz Pharmaceuticals (NASDAQ: JAZZ)
Evercore ISI Analyst forecast on DE:DY2
Elizabeth Anderson CFA
Evercore ISI
Evercore ISI
€13.17→€11.41
Hold
0.46%
Upside
Reiterated
04/08/26
Dentsply Sirona price target lowered to $13 from $15 at Evercore ISIDentsply Sirona price target lowered to $13 from $15 at Evercore ISI
Wells Fargo Analyst forecast on DE:DY2
Unknown Analyst
Wells Fargo
Not Ranked
Wells Fargo
€11.41
Hold
0.46%
Upside
Reiterated
02/27/26
Wells Fargo Keeps Their Hold Rating on DENTSPLY SIRONA (XRAY)
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
AVBPArriVent BioPharma, Inc.
BTSGBrightSpring Health Services, Inc.
MLYSMineralys Therapeutics, Inc.
ZURAZura Bio
TNYATenaya Therapeutics
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering DENTSPLY SIRONA

3 Months
Kevin CaliendoUBS
Success Rate
5/14 ratings generated profit
36%
Average Return
-2.89%
Copying Kevin Caliendo's trades and holding each position for 3 Months would result in 35.71% of your transactions generating a profit, with an average return of -2.89% per trade.
1 Year
Kevin CaliendoUBS
Success Rate
5/14 ratings generated profit
36%
Average Return
-7.41%
Copying Kevin Caliendo's trades and holding each position for 1 Year would result in 35.71% of your transactions generating a profit, with an average return of -7.41% per trade.
2 Years
Kevin CaliendoUBS
Success Rate
5/14 ratings generated profit
36%
Average Return
-17.70%
Copying Kevin Caliendo's trades and holding each position for 2 Years would result in 35.71% of your transactions generating a profit, with an average return of -17.70% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

DY2 Analyst Recommendation Trends

Rating
Mar 26
Apr 26
May 26
Jun 26
Jul 26
Strong Buy
0
0
5
6
6
Buy
5
4
2
0
0
Hold
14
10
9
8
10
Sell
2
3
4
4
3
Strong Sell
0
0
0
0
0
total
21
17
20
18
19
In the current month, DY2 has received 6 Buy Ratings, 10 Hold Ratings, and 3 Sell Ratings. DY2 average Analyst price target in the past 3 months is 12.14.
Each month's total comprises the sum of three months' worth of ratings.

DY2 Financial Forecast

DY2 Earnings Forecast

Next quarter’s earnings estimate for DY2 is €0.30 with a range of €0.27 to €0.36. The previous quarter’s EPS was €0.23. DY2 beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 56.99% of the time in the same period. In the last calendar year DY2 has Performed in-line its overall industry.
Next quarter’s earnings estimate for DY2 is €0.30 with a range of €0.27 to €0.36. The previous quarter’s EPS was €0.23. DY2 beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 56.99% of the time in the same period. In the last calendar year DY2 has Performed in-line its overall industry.

DY2 Sales Forecast

Next quarter’s sales forecast for DY2 is €771.87M with a range of €751.98M to €791.33M. The previous quarter’s sales results were €763.26M. DY2 beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 49.69% of the time in the same period. In the last calendar year DY2 has Performed in-line its overall industry.
Next quarter’s sales forecast for DY2 is €771.87M with a range of €751.98M to €791.33M. The previous quarter’s sales results were €763.26M. DY2 beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 49.69% of the time in the same period. In the last calendar year DY2 has Performed in-line its overall industry.

DY2 Stock Forecast FAQ

What is DE:DY2’s average 12-month price target, according to analysts?
Based on analyst ratings, DENTSPLY SIRONA’s 12-month average price target is 12.14.
    What is DE:DY2’s upside potential, based on the analysts’ average price target?
    DENTSPLY SIRONA has 6.90% upside potential, based on the analysts’ average price target.
      Can I see which stocks the top-ranking analysts are rating?
      Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
        How can I follow the stock ratings of top Wall Street analysts?
        Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
          Is DENTSPLY SIRONA a Buy, Sell or Hold?
          DENTSPLY SIRONA has a consensus rating of Hold, which is based on 3 buy ratings, 8 hold ratings and 2 sell ratings.
            What is DENTSPLY SIRONA’s share price target?
            The average share price target for DENTSPLY SIRONA is 12.14. This is based on 13 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
            The highest analyst share price target is €14.92 ,and the lowest forecast is €7.90. The average share price target represents 6.90% Increase from the current price of €11.36.
              What do analysts say about DENTSPLY SIRONA?
              DENTSPLY SIRONA’s analyst rating consensus is a Hold. This is based on the ratings of 13 Wall Streets Analysts.
                How can I buy shares of DENTSPLY SIRONA?
                To buy shares of DE:DY2, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.